All Stories

  1. The Use of Long-Acting Injectables for People with Schizophrenia: Consensus Panel Recommendations for Overcoming Barriers and Implementing Treatment
  2. Governing AI in Mental Health: A 50-State Legislative Analysis (Preprint)
  3. Governing AI in Mental Health: A 50-State Legislative Analysis (Preprint)
  4. Bridging Science and Hope: integrating and Communicating Lived experience in Accelerating Medicines Partnership® Schizophrenia Program
  5. Neurodiversity-informed inclusive understanding of neurological differences
  6. Plain language summary: development of the novel GlyT1 inhibitor, iclepertin (BI 425809), for the treatment of cognitive symptoms associated with schizophrenia
  7. Messiah or pariah? Psychosis, science, and finding meaning in lived experience
  8. Finding meaning in medication.
  9. Development of the PSYCHS: Positive SYmptoms and Diagnostic Criteria for the CAARMS Harmonized with the SIPS
  10. He Who Has Hope, Has Everything
  11. Youth Mental Health Screening and Care
  12. A Patient-Clinician Discussion of Current Challenges in Schizophrenia Part 1: Addressing Daily Functioning and Cognitive Impairments Associated with Schizophrenia [Podcast]
  13. Violence and schizophrenia: the role of social determinants of health and the need for early intervention
  14. Accelerating Medicines Partnership ® Schizophrenia (AMP ® SCZ): developing tools to enable early intervention in the psychosis high risk state
  15. Leading Science With Lived Experience
  16. Confidence, performance, and accuracy of self-assessment of social cognition: A comparison of schizophrenia patients and healthy controls
  17. Self-assessment in schizophrenia: Accuracy of evaluation of cognition and everyday functioning.